US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India

New Delhi, May 21: US pharmaceutical giant Gilead Sciences is likely to apply to India's Central Drugs Standard Control Organisation (CDSCO) soon seeking marketing authorisation for its anti-viral drug remdesivir, which is being considered by many as a potential medication for

from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/2ZryNfY

• Tweet
• Share
• Share
• Share
• Share

About Admin MC3

This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.

Related Post